Featured Research

from universities, journals, and other organizations

Random Gene Activation Helps Ulcer Bug Escape Immune System

Date:
November 23, 2004
Source:
Washington University School Of Medicine
Summary:
The bacterium that causes ulcers and contributes to stomach cancers uses a clever interaction between two genes to randomly tighten and loosen its grip on the stomach, according to a study by researchers at Washington University School of Medicine in St. Louis and Umeå University in Sweden.

St. Louis, Nov. 19, 2004 -- The bacterium that causes ulcers and contributes to stomach cancers uses a clever interaction between two genes to randomly tighten and loosen its grip on the stomach, according to a study by researchers at Washington University School of Medicine in St. Louis and Umeå University in Sweden.

Related Articles


Helicobacter pylori often binds tightly to cells of the stomach lining to feed, but the newly identified interaction ensures that a small reservoir of bacteria are always more loosely connected. This reservoir is much more likely to survive if the host mounts a strong immune response.

"Basically, if you're holding onto someone's T-shirt and they start punching you hard, you'd like to be able to let go," jokes Douglas Berg, Ph.D., Alumni Professor of Molecular Microbiology and an author of the study. "Any savvy bacteria are going to want to be able to do the same."

New insights into how H. pylori sticks to and then releases from the stomach wall will advance efforts to design better drugs and vaccines against the bacterium, which is estimated to be present in more than half of the world's population.

Most H. pylori infections in the U.S. and other industrialized nations can be treated with antibiotics, but treatments are too costly for many sufferers in underdeveloped nations, where the bacteria's pervasiveness and poor sanitation significantly increase the risk of repeat infections. In addition, resistance to standard drug therapies is a major problem in these countries.

The study appears in the online edition of Proceedings of the National Academy of Sciences. It will appear in print in the journal on November 30.

Researchers at Umeå University led by Anna Arnqvist, Ph.D., associate professor of molecular biology and medical biochemistry and a former Washington University predoctoral student, studied a Swedish strain of H. pylori. They focused on BabA, a protein that binds to Lewis B antigen receptor, a carbohydrate structure on the surface of stomach cells. Because they help organisms stick to particular targets in a glue-like fashion, BabA and proteins like it are collectively known as adhesins.

One of the Swedish strain's two copies of the gene for BabA is "silent," or blocked from use by damage in a region of DNA normally involved in the gene's activation. The second copy is missing an essential portion of DNA, making it completely nonfunctional.

"This suggested that the strain doesn't make BabA protein at all, making it equivalent in that regard to about one-third of all the other clinical isolates of H. pylori scientists have studied," Berg says.

Given that the strain didn't appear to produce BabA protein, the bacteria should have been unable to get a grip on the Lewis B receptor. However, scientists found that a small minority of the bacteria still stuck very tightly to Lewis B.

Researchers then determined that this resulted from the bacteria recombining DNA from the silent BabA gene and DNA from the gene for a similar protein, BabB. Scientists aren't sure what, if anything, BabB sticks to, but they do know that its similarities to BabA include biochemical "hooks" at the beginning and end of the protein. These hooks anchor the proteins in the bacteria's cell wall.

The BabA gene's middle section encodes the glue that makes the protein stick. The rare bacteria that could grip Lewis B had spliced that middle section from the silent BabA gene into BabB, providing themselves with the equivalent of a working BabA gene and its protein product.

BabA-BabB gene recombination is relatively rare because characteristics of the segments of DNA being combined make them technically difficult for the bacteria to splice together. In addition, the BabB gene has a built-in genetic feature that allows the gene to turn on and off irregularly as the bacteria reproduce.

"The BabB gene has a highly repetitive section that has a tendency to slip when the bacteria copies its DNA prior to cell division," Berg explains. "These slips can introduce extra repeats or delete them, shifting how the gene is translated from DNA to protein in a way that's likely to halt protein synthesis by introducing a premature stop signal."

The net result, according to Berg, is that the bacteria's ability to stick to the Lewis B receptor is metastable--in every generation, a small number of the new bacteria will switch from a tight grip to no grip, or vice-versa.

"This metastability is likely an important component of the bacteria's ability to adapt to host immune system responses," Berg says.

Berg and his Swedish colleagues are currently working to better understand BabB, investigating, among other things, whether the gene has a role to play on its own as a producer of a bacterial adhesin or only acts as a random enabler of BabA.

Among the approximately 30 H. pylori surface proteins so far known to scientists, researchers have found other pairs of closely related genes. Included in these pairs are other genes that code for surface adhesins.

"We also will take a close look at some of these pairs," Berg says. "We're eager to find out whether they contain variations of this special regulatory system in BabA and BabB, or whether they control the strength and specificity of H. pylori adherence in other ways."

###

Bäckström A, Lundberg C, Kersulyte D, Berg DE, Borén T, and Arnqvist A. Metastability of Helicobacter pylori genes and dynamics in Lewis B antigen binding. Proceedings of the National Academy of Sciences, November 30, 2004, 16923-16928.

Funding from the J.C. Kempe Memorial Foundation, the B von Kantzows Foundation, the Tore Nilsson Medical Research Foundation, the Magnus Bergwall Research Foundation, the Medical Faculty of Umeå University, the Kempestiftelserna, the Swedish Medical Research Council, the Swedish Cancer Society, the Umeå University-Washington University exchange program, and the National Institutes of Health.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Random Gene Activation Helps Ulcer Bug Escape Immune System." ScienceDaily. ScienceDaily, 23 November 2004. <www.sciencedaily.com/releases/2004/11/041122100101.htm>.
Washington University School Of Medicine. (2004, November 23). Random Gene Activation Helps Ulcer Bug Escape Immune System. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2004/11/041122100101.htm
Washington University School Of Medicine. "Random Gene Activation Helps Ulcer Bug Escape Immune System." ScienceDaily. www.sciencedaily.com/releases/2004/11/041122100101.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) — An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins